These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22416924)

  • 1. Impact of celebrity pitch in direct-to-consumer advertising of prescription drugs.
    Bhutada NS; Menon AM; Deshpande AD; Perri M
    Health Mark Q; 2012; 29(1):35-48. PubMed ID: 22416924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors.
    Bhutada NS; Rollins BL
    Res Social Adm Pharm; 2015; 11(6):891-900. PubMed ID: 25797861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
    Bhutada NS; Rollins BL; Perri M
    Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. But it's doctor recommended and I read the fine print: antecedents to drug companies' perceived credibility.
    Park JS; Hoy MG
    Health Mark Q; 2013; 30(1):63-79. PubMed ID: 23458482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTC drug advertising in Japan: the role of need for cognition and celebrity endorser credibility.
    Morimoto M
    Health Mark Q; 2020; 37(2):108-123. PubMed ID: 32208968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric responsiveness of physician prescription behavior to drug promotion of competitive brands within an established therapeutic drug class.
    Pedan A; Wu H
    Health Mark Q; 2011 Apr; 28(2):133-54. PubMed ID: 21590561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective.
    Deshpande A; Menon A; Perri M; Zinkhan G
    J Health Commun; 2004; 9(6):499-513. PubMed ID: 15764449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
    Lemanski JL; Villegas J
    Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitude toward direct-to-consumer advertising and drug inquiry intention: the moderating role of perceived knowledge.
    An S
    J Health Commun; 2007 Sep; 12(6):567-80. PubMed ID: 17763053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumers young and old: segmenting the target markets for direct-to-consumer prescription drug advertising.
    Ball JG; Manika D; Stout P
    Health Mark Q; 2011 Oct; 28(4):337-53. PubMed ID: 22054029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 16. A content analysis of direct-to-consumer television prescription drug advertisements.
    Kaphingst KA; DeJong W; Rudd RE; Daltroy LH
    J Health Commun; 2004; 9(6):515-28. PubMed ID: 15764450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumers' preferences for the communication of risk information in drug advertising.
    Davis JJ
    Health Aff (Millwood); 2007; 26(3):863-70. PubMed ID: 17485767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.
    Brownfield ED; Bernhardt JM; Phan JL; Williams MV; Parker RM
    J Health Commun; 2004; 9(6):491-7. PubMed ID: 15764448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food choice and overconsumption: effect of a premium sports celebrity endorser.
    Boyland EJ; Harrold JA; Dovey TM; Allison M; Dobson S; Jacobs MC; Halford JC
    J Pediatr; 2013 Aug; 163(2):339-43. PubMed ID: 23490037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.